Table 2.
Summary of patient numbers and individual patient-reported outcome observations included in analysis
| Patients included, n | Maximum observations per patient, n | Total observations used in analysis, n | |
|---|---|---|---|
| PP-NRS vs NTIS | 391 | 6 | 1966 |
| PP-NRS vs POEM sleep item | 390 | 5 | 1685 |
| PP-NRS vs SCORAD Sleep Loss VAS | 390 | 5 | 1691 |
| PP-NRS vs WPAIa | 220 | 2 | 357 |
| NTIS vs POEM sleep item | 389 | 5 | 1578 |
| NTIS vs SCORAD Sleep Loss VAS | 389 | 5 | 1583 |
| NTIS vs WPAIa | 219 | 2 | 341 |
| SCORAD Sleep Loss VAS vs POEM sleep item | 391 | 5 | 1842 |
NTIS Night Time Itch Scale, POEM Patient-Oriented Eczema Measure, PP-NRS Peak Pruritus Numerical Rating Scale, SCORAD Sleep Loss VAS SCORing of Atopic Dermatitis Sleep Loss Visual Analog Scale, WPAI-AD Work Productivity and Activity Impairment-Atopic Dermatitis
aWPAI overall work impairment